January 12, 2015
Gilead Sciences to Present at the 33rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 13
Webcast Available Through Gilead Corporate Website
FOSTER CITY, Calif.--(BUSINESS WIRE)--Jan. 12, 2015--
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate
presentation will be webcast from the 33rd Annual J.P. Morgan
Healthcare Conference in San Francisco.
John F. Milligan, PhD, Gilead’s President and Chief Operating Officer,
will provide an overview of the company at the conference on Tuesday,
January 13 at 8:30 a.m. Pacific Time (11:30 a.m. Eastern Time).
To access the live webcast or a replay via the internet log on to www.gilead.com.
Please connect to the company’s website at least 15 minutes prior to the
start of the presentation to ensure adequate time for any software
download that may be necessary to listen to the webcast. The replay will
be available for 14 days following the presentation.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the care of patients suffering
from life-threatening diseases. Gilead has operations in more than 30
countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s
website at www.gilead.com,
follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs
at 1-800-GILEAD-5 or 1-650-574-3000.
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936
Investor
Relations
